OSR Holdings Updates Equity Financing Instruments, Dilution Limited to Less Than 10%

OSR Holdings, a global healthcare company, provided a transparency update on its Equity Line of Credit (ELOC) agreement with White Lion GBM Innovation Fund. The company issued a total of 2,308,382 shares under structured financing, with less than 10% of the registered shares issued under the ELOC. OSRH is investing proceeds from these financings into its business, enabling accelerated development across its drug R&D pipeline, medical device initiatives, and digital asset ecosystems.